Quentis, an immuno-oncology therapy developer based on research at Weill Cornell Medicine, has closed a round that included Taiho Pharmaceuticals and AbbVie Ventures.

Continental Grain was among the investors in the vegan dairy protein developer's $24.7m round, which was led by Temasek.

The Global University Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing university funds.

OpenText Enterprise Apps Fund co-led the design collaboration software startup's $5.8m series A round with BDC Capital.

The immuno-oncology therapy startup has completed a round that included Taiho Pharmaceuticals and AbbVie Ventures.

Adaptive drug technology developer Senti has completed a New Enterprise Associates-led series A round that included Amgen Ventures.

The MedImmune spinout is targeting inflammation and autoimmune diseases, and will be equipped with up to $250m of series A funding.

The Medical Research Commercialisation Fund has supplied series A capital to Okogen as the company partners University of Sydney to develop a treatment for viral conjunctivitis.

The Netherlands-based parking spot finder has closed a $6.1m round led by Statkraft Ventures that will fund hiring and a UK expansion.